Cargando…
Preferred Features of Oral Treatments and Predictors of Non-Adherence: Two Web-Based Choice Experiments in Multiple Sclerosis Patients
BACKGROUND: Oral disease modifying therapies (DMTs) for multiple sclerosis (MS) differ in efficacy, tolerability, and safety. OBJECTIVE: We sought to understand how these attributes impact patient preference and predicted DMT non-adherence among oral-naïve MS patients. METHODS: Adult MS patients fro...
Autores principales: | Wicks, Paul, Brandes, David, Park, Jinhee, Liakhovitski, Dimitri, Koudinova, Tatiana, Sasane, Rahul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376178/ https://www.ncbi.nlm.nih.gov/pubmed/25749630 http://dx.doi.org/10.2196/ijmr.3776 |
Ejemplares similares
-
The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis
por: Wicks, Paul, et al.
Publicado: (2016) -
Treatment preferences in relation to fatigue of patients with
relapsing multiple sclerosis: A discrete choice experiment
por: Tervonen, Tommi, et al.
Publicado: (2023) -
Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record review
por: Nazareth, Tara, et al.
Publicado: (2016) -
Teriflunomide for the treatment of relapsing–remitting multiple sclerosis: patient preference and adherence
por: Bayas, Antonios, et al.
Publicado: (2015) -
Oral Sensitivity to Flowability and Food Neophobia Drive Food Preferences and Choice
por: Puleo, Sharon, et al.
Publicado: (2021)